Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Unknown 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1Genitourinary 1

Conditions

Uterine Cervical Neoplasms 1Testicular Neoplasms 1Teratoma 1Ovarian Neoplasms 1Ovarian Germ Cell Cancer 1

Interventions

Carboplatin 8Etoposide 7Filgrastim 5Bleomycin 5Ifosfamide 4Cisplatin 4Thiotepa 3Peripheral Blood Stem Cell Transplantation 3Paclitaxel 3Granulocyte Colony-Stimulating Factor 3etoposide phosphate 2Temozolomide 2Taxes 2Amifostine 2sodium thiosulfate 1ixabepilone 1Vinblastine 1Surgical Procedures, Operative 1Reverse Transcriptase Polymerase Chain Reaction 1Restraint, Physical 1Radiotherapy 1Psychiatric Rehabilitation 1PT-100 dipeptide 1Oxaliplatin 1O(6)-benzylguanine 1Microarray Analysis 1Mesna 1Melphalan 1Immunohistochemistry 1Hematologic Tests 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Ovarian Germ Cell Cancer × Vinblastine × Gynecologic × Clear all
NCT00274950 2013-09-17

Observation and/or Combination Chemotherapy After Surgery or Biopsy in Treating Young Patients With Extracranial Germ Cell Tumors

National Cancer Institute (NCI)

Phase 3 Unknown
105 enrolled
GenitourinaryGynecologic

Ovarian Germ Cell Cancer, Ovarian Neoplasms, Teratoma, Testicular Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡